Improved bleeding profile and tolerability of tibolone versus transdermal E₂/NETA treatment in postmenopausal women with female sexual dysfunction

Abstract

Tibolone has a significantly better tolerability profile than transdermal E(2)/NETA as measured by vaginal bleeding, breast pain and treatment continuation.